KSKen Suzawa

Ken Suzawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ken Suzawa has a total of 340 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pulmonary-abdominal normothermic regional perfusion enables in situ lung evaluation in donation after circulatory death: A comparative study with conventional abdominal normothermic regional perfusion

    by Masashi Umeda, Shin Tanaka, Kaoru Kondo, Tsuyoshi Ryuko, Hiroyuki Ujike, Haruki Choshi, Shinichi Kawana, Haruchika Yamamoto, Kumi Nakajima, Hidejiro Torigoe, et al.

  • Radiological Predictors of Visceral Pleural Invasion in Lung Cancers With Ground-Glass Opacity and Pleural Contact

    by Naohiro Hayashi, Ken Suzawa, Midori Filiz Nishimura, Haruchika Yamamoto, Kumi Nakajima, Shin Tanaka, Hidejiro Torigoe, Kazuhiko Shien, Kentaroh Miyoshi, Mikio Okazaki, et al.

  • Distinct recurrence patterns related to preoperative treatment decisions for patients with locally advanced non-small cell lung cancer

    by Kazuhiro Okada, Ken Suzawa, Tsuyoshi Ryuko, Anna Rogachevskaya, Yusuke Otani, Yasuaki Tomioka, Shin Tanaka, Hidejiro Torigoe, Kazuhiko Shien, Kentaroh Miyoshi, et al.

    Locally advanced non-small cell lung cancer (LA-NSCLC) is a heterogeneous disease that requires tailored treatment strategies. This study investigates the correlation between T and N factors and postoperative recurrence patterns to refine therapeutic approaches. The subjects of this retrospective cohort study were 193 patients with LA-NSCLC, who underwent trimodality therapy between 1999 and 2021. Tumors were categorized as Nodal-Dominant (ND) LA-NSCLC (T1-2 with advanced nodal involvement) or Tumor-Dominant (TD) LA-NSCLC (T3-4 with limited nodal involvement). We compared recurrence patterns and survival outcomes between the two groups. The 193 patients comprised 83 with ND-LA-NSCLC and 110 with TD-LA-NSCLC. The patients with ND-LA-NSCLC had a significantly higher rate of distant metastasis than those with TD-LA-NSCLC (50.6% vs. 26.4%, P = 0.001). The patients with TD-LA-NSCLC had significantly better 5-year disease-free survival (DFS) than those with ND-LA-NSCLC (62.4% vs. 37.2%, P < 0.001). ND-LA-NSCLC is associated with a higher risk of distant metastatic recurrence, underscoring the need for more effective systemic therapies before surgery. Conversely, TD-LA-NSCLC exhibits superior local disease control, reinforcing the role of intensive local therapies. These findings emphasize the importance of tumor classification based on T and N factors for optimizing perioperative treatment strategies for LA-NSCLC.

  • Open Access

    Radiological Predictors of Visceral Pleural Invasion in Lung Cancers with Ground-Glass Opacity and Pleural Contact

    by Naohiro Hayashi, Ken Suzawa, Midori Filiz Nishimura, Haruchika Yamamoto, Kumi Nakajima, Shin Tanaka, Hidejiro Torigoe, Kazuhiko Shien, Kentaroh Miyoshi, Mikio Okazaki, et al.

    BackgroundVisceral pleural invasion (VPI) remains a critical factor influencing surgical decision-making in non-small cell lung cancer (NSCLC). However, accurately predicting VPI on radiological images remains challenging in lung cancers.Materials and MethodsThis retrospective study analyzed 299 cases of NSCLC with pleural contact and ground-glass opacity (GGO) components on thin-section CT, all of which were surgically treated between 2012 and 2019. Clinical and radiological features were evaluated for their predictive value in detecting VPI.ResultsVPI was confirmed in 14 cases (4.7%). Univariate analysis revealed significant associations between VPI and part-solid tumors (p = 0.025), larger tumor diameter (p = 0.006), greater solid component size (p < 0.001), higher consolidation-to-tumor ratio (CTR) (p = 0.001), increased pleural contact length (p < 0.001), elevated CT attenuation values (p < 0.001), and SUVmax on FDG-PET (p < 0.001). No cases of pathological VPI were observed in lesions where only the GGO component was in contact with the pleura.ConclusionSpecific radiological features can serve as reliable predictors of non-VPI in ground-glass nodules with pleural contact. Notably, VPI was absent in tumors where only the GGO component contacted the pleura. These findings underscore the importance of careful preoperative evaluation for non-VPI, incorporating additional imaging parameters to enhance risk stratification and surgical decision-making.

  • Open Access

    Longitudinal spatial transcriptomics reveals the molecular dynamics of pulmonary artery remodeling in pulmonary arterial hypertension

    by Haruki Choshi, Seiichiro Sugimoto, Shuta Tomida, Tatsuya Hayashi, Atsushi Matsuoka, Toshiaki Ohara, Yasuaki Tomioka, Shin Tanaka, Ken Suzawa, Kazuhiko Shien, et al.

  • Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study)

    by Kazuki Hayasaka, Mototsugu Shimokawa, Naoki Haratake, Hirotsugu Notsuda, Shinya Katsumata, Akira Hamada, Kotaro Nomura, Kosuke Fujino, Mao Yoshikawa, Ken Suzawa, et al.


  • Open Access

    Association Between Early Posttransplant Graft Perfusion and CLAD‐Free Survival After Single Lung Transplantation

    by Shin Tanaka, Megumi Ishihara, Yujiro Kubo, Haruchika Yamamoto, Kumi Nakajima, Hidejiro Torigoe, Shuji Okahara, Kazuhiko Shien, Ken Suzawa, Kentaroh Miyoshi, et al.

    Background: The physiological relevance of postoperative perfusion distribution after single lung transplantation (SLT) remains poorly defined, as asymmetric blood flow toward the graft is often regarded as an inherent consequence of the remaining native lung. This study aimed to determine whether the graft‐directed perfusion ratio assessed by quantitative lung perfusion scintigraphy (QLPS) in the early postoperative period serves as an early physiological marker after SLT. Methods: We retrospectively analyzed SLT recipients who underwent surgery at Okayama University Hospital between 1998 and 2021 and completed QLPS approximately 3 months posttransplant. The graft perfusion ratio (graft flow/total pulmonary flow × 100%) was quantified, and recipients were classified into high (≥ 80%) and low (< 80%) perfusion groups. CLAD‐free survival, overall survival, and longitudinal perfusion changes were compared using Kaplan–Meier analysis and repeated‐measures ANOVA. Results: Recipients with higher graft perfusion demonstrated significantly better CLAD‐free survival ( p = 0.027). Overall survival was higher in the high‐perfusion group, although the difference did not reach statistical significance ( p = 0.075). Repeated‐measures ANOVA revealed a significant group‐by‐time interaction ( p = 0.019): recipients who developed CLAD had lower graft perfusion as early as 3 months after transplantation, followed by a progressive decline, whereas those who did not develop CLAD maintained stable perfusion. In the multivariable Cox analysis, higher graft perfusion was associated with a lower hazard of reaching the composite CLAD‐free survival endpoint. Conclusions: Early postoperative graft perfusion assessed by QLPS may serve as a noninvasive physiological marker after SLT. Higher graft‐directed perfusion was associated with a lower hazard of reaching the composite CLAD‐free survival endpoint and may aid early risk stratification and posttransplant surveillance.

  • Open Access

    Tailored Management of Anomalous Systemic Arterial Supply to the Basal Segment of the Lung: A Case Report and Literature Review

    by Shunsuke Mori, Ken Suzawa, Koji Tomita, Haruchika Yamamoto, Kumi Nakajima, Shin Tanaka, Hidejiro Torigoe, Kazuhiko Shien, Kentaroh Miyoshi, Mikio Okazaki, et al.

    INTRODUCTION: Parenchyma-preserving strategies for anomalous systemic arterial supply to the basal segment of the lung have gained increasing attention. However, pulmonary infarction of the preserved lung has been reported, and clear criteria for selecting the optimal treatment have yet to be established. We report 2 cases in which detailed preoperative imaging informed tailored management—right posterior basal segmentectomy in 1 patient and endovascular embolization of the aberrant artery in the other—both without postoperative complications. A review of the relevant literature is also provided, with an emphasis on potential selection criteria.CASE PRESENTATION: Case 1: A 20-year-old asymptomatic woman was referred after an abnormal screening chest radiograph. CT demonstrated an aberrant artery arising from the abdominal aorta supplying the right posterior basal segment (S10) with a large intravascular thrombus. The pulmonary artery showed hypoplasia limited to A10, while the other branches were normal, and no parenchymal congestion was identified. Following resection of the aberrant artery, robot-assisted right S10 segmentectomy was performed. The postoperative course was uneventful, and the patient was discharged on POD 6. Case 2: A 27-year-old woman was incidentally diagnosed on CT for an unrelated indication. An aberrant artery arising from the descending thoracic aorta supplied the left basal segment. Pulmonary arterial branches were preserved, with only minimal congestion in S9-10. Angiography revealed no evidence of an arteriovenous fistula. As surgical lung resection was considered unnecessary, coil embolization of the aberrant artery was performed. No complications occurred, and the patient was discharged on day 3 after the procedure.CONCLUSIONS: In patients with anomalous systemic arterial supply to the basal segment of the lung, when pulmonary arterial branches are preserved and background parenchymal congestion is minimal, parenchyma-sparing approaches should be considered.

  • Open Access

    A multicenter retrospective study on surgical outcomes of lobectomy with pulmonary arterioplasty versus pneumonectomy for centrally-located left upper lobe non-small cell lung cancer

    by Mao Yoshikawa, Hiroyuki Tao, Hisao Mizutani, Mototsugu Watanabe, Ken Suzawa, Tsuyoshi Ueno, Yuho Maki, Mikio Okazaki, Riki Okita, Daisuke Okutani, et al.

  • Open Access

    Single-cell and spatial transcriptomic characterization of pulmonary pleomorphic carcinoma

    by Atsushi Matsuoka, Kazuhiko Shien, Shuta Tomida, Masayoshi Ohki, Kazuya Hisamatsu, Ryota Fujiwara, Kosei Ishimura, Ryunosuke Fujii, Tomoaki Higashihara, Naohiro Hayashi, et al.

    Pulmonary pleomorphic carcinoma (PPC) is a rare subtype of lung cancer that comprises both epithelial and sarcomatoid components. The molecular basis of PPC, including the cellular dynamics of its components, remains largely unknown. To elucidate potential therapeutic targets for PPC, we perform a multi-omics analysis incorporating digital spatial profiling and single-cell RNA sequencing (scRNA-seq). PPC exhibits diverse driver gene alterations, including MET exon 14 skipping mutation (METex14) and ALK fusion. In spatial transcriptomics, MET gene and protein are overexpressed exclusively within the epithelial component and not in the sarcomatoid component, even in patients harboring METex14. Epithelial-mesenchymal transition (EMT)-related transcriptional changes, along with extracellular matrix (ECM) remodeling between the epithelial and sarcomatoid components, are observed. scRNA-seq identifies cell populations within the epithelial component that contribute to the malignant transformation and differentiation of the sarcomatoid component. They are characterized by an intermediate EMT state with ECM remodeling signature, suggesting their potential as novel therapeutic targets for PPC.